Companies: 10,795·Total market cap: $144.5T

GH Research PLC

GH Research PLC

GHRSNASDAQHealthcare● Active

$20.12

$-1.31(-6.11%)

Market Cap$1.4B

P/E Ratio—

52W High$25.94

52W Low$11.32

Avg Volume239K

Open$21.68

Beta1.31

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

GH Research PLC（GHRS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GHRS · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.92Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding61.0MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 GH Research PLC 数据

分析师预测$41 · Buy

股息不分红

盈利EPS $-0.79-5.33%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$48.3M▼ 23.86% YoY

202320242025

FY 2025EPS$-0.79▼ 5.33% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$56.4MEPS: $-0.92View income statement →

分析师评级与目标价

Buy9 位分析师

Strong Buy

0

Buy

9

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$32.00Low

$20.12Current

$40.57Avg Target上涨空间 101.64%

$65.00High

合计: 9 · 买入占比: 100.0%

根据过去 3 个月内 9 位华尔街分析师，GHRS 共识评级为 Buy，12 个月平均目标价 $40.57 （较现价 $20.12 上涨空间 101.64%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

GH Research PLC

$20.12-6.11%$1.4B #2

Arbutus Biopharma Corporation

$4.24-0.24%$837.6M #3

Kura Oncology, Inc.

$8.56-2.06%$759.9M #4

LENZ Therapeutics, Inc.

$6.72-4.14%$210.7M #5

Nanobiotix S.A.

$35.70+1.18%$1.8B #6

ProKidney Corp.

$1.71-5.00%$253.4M

股票表现

1D-5.24%

1W-18.28%

1M-5.19%

3M+27.48%

YTD+59.91%

1Y+48.23%

5Y+5.50%

关于 GH Research PLC

CEOVelichka Valcheva

IPO DateJun 25, 2021

Employees50

CountryIE

Websiteghres.com

GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy…

Biotechnology HealthcareNASDAQIE

关于股票概览与关键数据

GH Research PLC（GHRS）是 Biotechnology 行业的 Healthcare 类公司，于 Jun 25, 2021 在 NASDAQ 上市。截至最近交易日，GHRS 股价为 $20.12，市值约为 $1.4B。过去12个月累计回报 +48.23%，年初至今回报 +59.91%。

根据 9 位华尔街分析师，GH Research PLC 股票共识评级为Buy，12个月平均目标价为 $40.57。2025 财年 GH Research PLC 营收 —，净利润 -$48.3M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，GH Research PLC（GHRS）股价为 $20.12，在 NASDAQ 上市，52周区间为 $11.32 – $25.94。

GHRS 最新股价GHRS quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议